Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF

By rosaguerrero • June 21, 2022

Chapman B, Hellkamp AS, Thomas LE, Albert NM, Butler J, Patterson JH, Hernandez AF, Williams FB, Shen X, Spertus JA, Fonarow GC, DeVore AD. Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF. J Am Heart Assoc. 2022 Jun 20;11(12):e022889. doi: 10.1161/JAHA.121.022889. Epub ahead of print. PMID: 35722989; PMCID: PMC9238653.

Tags: angiotensin receptor neprilysin inhibitor, Cardiology/Epi, heart failure, population groups, Publications, registries, sacubitril/valsartan

Complex Tricuspid and Pulmonic Carcinoid Heart Disease With Timely Surgical Repair

Hollowed J, Woo H, Hamburg S, Ardehali A. Complex Tricuspid and Pulmonic Carcinoid Heart Disease With Timely Surgical Repair. Tex Heart Inst J. 2025 Jul[...]

Pushing the Limits of LDL Cholesterol: Emerging Paradigms in Cardiovascular Risk Reduction

Yaghoubi D, Sallam T. Pushing the Limits of LDL Cholesterol: Emerging Paradigms in Cardiovascular Risk Reduction. Trends Cardiovasc Med. 2025 Jul 13:S1050-1738(25)00094-5. doi: 10.1016/j.tcm.2025.07.002. Epub[...]

Human formin FHOD3-mediated actin elongation is required for sarcomere integrity in cardiomyocytes

Valencia DA, Koeberlein AN, Nakano H, Rudas A, Patel AA, Harui A, Spencer C, Nakano A, Quinlan ME. Human formin FHOD3-mediated actin elongation is required[...]